Research Applications of Levetiracetam 250mg Tablets
Keppra 250 mg is a pharmaceutical-grade levetiracetam preparation designed for in-vitro neurological research. This antiepileptic compound enables researchers to investigate synaptic vesicle protein SV2A binding mechanisms and GABAergic neurotransmission pathways. Scientists at Stroid UK Shop utilise these standardised tablets to examine voltage-gated calcium channel modulation and neuronal excitability regulation in laboratory settings.
Pharmaceutical Research Standards
Each Keppra tablet delivers consistent 250mg levetiracetam dosing for reproducible experimental protocols. Researchers studying epileptogenesis mechanisms benefit from the pharmaceutical formulation’s stability and bioavailability profile. The compound’s unique binding affinity for synaptic vesicle glycoprotein SV2A makes it valuable for investigating presynaptic neurotransmitter release dynamics. Laboratory studies examining levetiracetam preparations demonstrate its distinctive pharmacological profile compared to traditional GABA receptor modulators.
Technical Specifications
| Parameter | Value |
|---|---|
| Active Compound | Levetiracetam |
| Strength | 250mg per tablet |
| CAS Number | 102767-28-2 |
| Molecular Formula | C₈H₁₄N₂O₂ |
| Molecular Weight | 170.21 g/mol |
| Storage Conditions | Room temperature, dry environment |
Laboratory Applications
Neurochemistry laboratories investigate levetiracetam’s novel mechanism through SV2A protein interactions, distinguishing it from classical antiepileptic compounds targeting sodium or calcium channels. Research protocols examine its effects on kindling models and seizure threshold modulation. The pharmaceutical tablet format ensures precise dosing for comparative studies against other neurological research compounds available through our SARMs collection and peptide research materials. Investigators study its neuroprotective properties and synaptic plasticity effects in various experimental paradigms.
Research Use Compliance
Keppra 250mg tablets are supplied exclusively for in-vitro laboratory research purposes. This pharmaceutical preparation is not intended for human consumption, clinical use, or therapeutic applications. Researchers must comply with institutional guidelines and applicable regulations when conducting studies with this neurological research compound.
